Search results for "dosing"

Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood. Insulin functions like a key, unlocking muscle and...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia

Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia

OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C (compound name: OLX72021), an...
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
When Supplements Turn Toxic: The Hidden Risks of Over-Dosing on Calcium and Vitamin D

When Supplements Turn Toxic: The Hidden Risks of Over-Dosing on Calcium and Vitamin D

While nutrients found in natural foods rarely cause significant side effects even when consumed in large amounts,...
Experimental Cancer Drug ACR-2316 Triggers Complete Remission in Advanced Lung Cancer Patient

Experimental Cancer Drug ACR-2316 Triggers Complete Remission in Advanced Lung Cancer Patient

An advanced lung cancer patient who had previously undergone multiple rounds of systemic therapy achieved a "complete...
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year

Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year

The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its...
Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung announced on the 19th that it has completed patient enrollment for the Phase 2 clinical trial of its...
Blood Sugar Control Improves After 65: Why Age Alone Should Not Dictate Type 1 Diabetes Care

Blood Sugar Control Improves After 65: Why Age Alone Should Not Dictate Type 1 Diabetes Care

Type 1 and type 2 diabetes stem from fundamentally different underlying etiologies. In type 1 diabetes, an autoimmune...
GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell announced on Sept. 18 that South Korea’s Ministry of Food and Drug Safety has approved the compassionate use of...
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026

Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026

Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...